What is the role for idelalisib and duvelisib in CLL?
Trial results of venetoclax plus CHOP therapy with rituximab or obinutuzumab in non-Hodgkin lymphoma
How to generate an anticancer immune response in multiple myeloma
Venetoclax for multiple myeloma - mechanism of action and next steps
Selinexor for CLL - mechanism of action and combination with ibrutinib